Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BB Biotech AGXSWX:BION -0.10%34 EV-to-OCF is 6.04 as of Jul. 18, 2026, which is 56% below its 10-year median of 13.66. GuruFocus rates XSWX:BION with a GF Score™ of 34/100. The stock has 4 warning signs investors should review. Among 1,411 Biotechnology companies, BB Biotech AG ranks worse than 80.94% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, BB Biotech AG's Enterprise Value is CHF2,377.7 Mil.
BB Biotech AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was CHF393.7 Mil. Therefore, BB Biotech AG's EV-to-OCF for today is 6.04.
The historical rank and industry rank for BB Biotech AG's EV-to-OCF or its related term are showing as below:
XSWX:BION'
s EV-to-OCF Range Over the Past 10 Years
Min: -131.67 Med: 13.66 Max: 1496.78
Current: 6.04
During the past 13 years, the highest EV-to-OCF of BB Biotech AG was 1496.78. The lowest was -131.67. And the median was 13.66.
XSWX:BION's EV-to-OCF is ranked worse than 80.94% of 1411
companies
in the Biotechnology industry
Industry Median: -3.28
vs XSWX:BION: 6.04
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
BB Biotech AG's PE Ratio (TTM) for today is calculated as:
BB Biotech AG's share price for today is CHF49.55.
BB Biotech AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF14.540.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
BB Biotech AG EV-to-OCF Related Terms
BB Biotech AG EV-to-OCF Historical Data
* Premium members only.
The historical data trend for BB Biotech AG's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:BION vs VRTX, REGN, ALNY: EV-to-OCF Comparison
For the Biotechnology subindustry, BB Biotech AG's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BB Biotech AG EV-to-OCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BB Biotech AG's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where BB Biotech AG's EV-to-OCF falls into.
BB Biotech AG's current Enterprise Value is CHF2,377.7 Mil.
BB Biotech AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF393.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BB Biotech AG (XSWX:BION) has a EV-to-OCF of 6.04 as of Jul. 18, 2026. This is 56% below median its historical median of 13.66. According to the industry distribution chart, BB Biotech AG ranks #1142 out of 1411 companies in the Biotechnology industry, placing it in the top 80.9%.
Is BB Biotech AG's EV-to-OCF too high?
BB Biotech AG's current EV-to-OCF of 6.04 is 56% below median its 10-year median of 13.66. Based on the distribution chart, BB Biotech AG ranks #1142 out of 1411 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, BB Biotech AG has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's EV-to-OCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BB Biotech AG ranks #1142 out of 1411 companies for EV-to-OCF. This places BB Biotech AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. BB Biotech AG's current EV-to-OCF is 6.04, which is 56% below median its own 10-year median of 13.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (XSWX:BION) has a current EV-to-OCF of 6.04. The current EV-to-OCF is 6.04, which is 56% below median its 10-year median of 13.66. BB Biotech AG's overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For BB Biotech AG (XSWX:BION), the current EV-to-OCF is 6.04 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
34GF Score
Get the complete analysis for XSWX:BION
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:BION has been successfully added to your 
